Public Policy

In 2015 and 2016, ASHG submitted comments to the U.S. Food and Drug Administration (FDA) on two related proposed regulations for Next Generation Sequencing (NGS)-based in vitro diagnostics. Appreciative of being engaged in the process, ASHG submitted comments to further inform and clarify the issue. Related: Comments on “Use of Standards in FDA Regulatory Oversight... Read More

ASHG Media Advisory Media Contact: Nalini Padmanabhan ASHG Communications Manager 301.634.7346 press@ashg.org For Immediate Release Tuesday, July 28, 2015 2:00 pm U.S. Eastern Time (UTC-05:00) WHEN: Tuesday to Saturday, Oct. 6-10, 2015 WHERE: Baltimore Convention Center, 1 West Pratt Street, Baltimore, MD 21201 WHAT: Invited and platform (oral) sessions and other presentations of the latest... Read More

S. 2744, the Genetic Research Privacy Protection Act, was introduced in the Senate in 2016. This bill, supported by ASHG, would guard against the inappropriate use of the Freedom of Information Act to gain access to research participants’ genetic information, and would build on existing privacy protections by strengthening Certificates of Confidentiality. Its provisions were... Read More

H.R.1313, the Preserving Employee Wellness Programs Act, a 2017 bill, would fundamentally undermine privacy provisions of the Genetic Information Nondiscrimination Act (GINA) and the Americans with Disabilities Act (ADA). Related: Group Letter to House Leaders Opposing H.R. 1313 (March 2017) Letter to House Leaders Opposing H.R. 1313 (March 2017) Press Release: ASHG Opposes H.R. 1313,... Read More

Media Contact: Nalini Padmanabhan ASHG Communications Manager 301.634.7346 press@ashg.org For Immediate Release Tuesday, October 14, 2014 12:00 pm U.S. Pacific Time (UTC-05:00) WHEN: Saturday through Wednesday, Oct. 18-22, 2014 WHERE: American Society of Human Genetics 2014 Annual Meeting San Diego Convention Center, 111 W. Harbor Drive, San Diego, CA 92101 WHAT: Invited and platform (oral)... Read More